SCHEMBL3468299

SCHEMBL3468299

CC(=O)Nc1ccc(-c2ccc(CCC(CCCc3ccccc3)C(=O)O)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.52
SMN1; SMN2 Q16637 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
MMP3 P08254 5/20 0.48
MMP2 P08253 5/20 0.48
GRIK1 P39086 1/20 0.48
HTT P42858 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 2/20 0.47
POLB P06746 1/20 0.47
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MME P08473 1/20 0.46
USP2 O75604 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1859446 0.96 PTPN1 (0.56) PTPN1SMN1; SMN2KDM4ELMNAMMP3
SCHEMBL3466490 0.90 CYP17A1 (0.52) MMP3MMP2MME
SCHEMBL3467061 0.89 SMN1; SMN2 (0.47) PTPN1SMN1; SMN2KDM4ELMNAMMP3
SCHEMBL1861903 0.85 GRIK1 (0.59) MMP3MMP2GRIK1MME
SCHEMBL1863843 0.85 SMN1; SMN2 (0.50) PTPN1SMN1; SMN2KDM4ELMNAMMP3
SCHEMBL4222929 0.83 CYP2C9 (0.49) PTPN1SMN1; SMN2KDM4ELMNAHTT
SCHEMBL1859143 0.83 GRIK1 (0.56) SMN1; SMN2MMP3MMP2GRIK1MAPT
SCHEMBL1860416 0.81 GRIK1 (0.68) SMN1; SMN2MMP3MMP2GRIK1MAPT
SCHEMBL7077494 0.81 MMP2 (0.69) KDM4ELMNAMMP3MMP2HTT
SCHEMBL7078108 0.81 NPC1 (0.50) PTPN1SMN1; SMN2KDM4ELMNAMMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed